AIDS News and Research

RSS

Importance of the drug Fuzeon (enfuvirtide) in the management of HIV

New potent combinations make suppression of virus to undetectable levels more achievable for treatment-experienced HIV patients.

20 Oct 2005

US Congress has wasted an opportunity to tackle the rising numbers of chronically hungry people in the world

On World Food Day, Oct 16, the World Food Programme (WFP) delivered some disquieting news: the number of chronically hungry people is rising again after decades of decline. Almost 6·5 million people have died so far this year from hunger and related diseases, which claim more lives than AIDS, malaria, and tuberculosis combined.

20 Oct 2005

Zambia to try 'herbal remedy' as a treatment for HIV/AIDS

The United Nations paints a grim picture of the health situation in Zambia. One in every six adults in Zambia is living with HIV, life expectancy at birth is below 40 years and 630,000 children in Zambia are AIDS orphans.

20 Oct 2005

Survival rate of HIV-infected patients in India has risen in response to a 20-fold drop in the price of antiretroviral therapy

Many of the more than 5 million HIV-infected people living in India have been unable to obtain treatment due to the high cost. With the introduction of generic ART into India in 2000, the price of HIV drugs fell from $778 per month to $100 per month, and eventually declined even further to just $33 per month in 2003.

19 Oct 2005

Third nationwide polio drive in Indonesia in attempt to eliminate the disease

Indonesia which is still battling to eliminate the recurring outbreak of polio, will hold a third nationwide polio immunisation drive in November to try to finally stamp out the crippling disease.

19 Oct 2005

HIV drug combo Trimethoprim-sulfamethoxazole highly effective at preventing malaria

A drug combination used to prevent pneumonia and opportunistic bacterial infection in persons with HIV/AIDS has unexpectedly been found to be highly effective at preventing malaria, according to a study published in the November 15 issue of The Journal of Infectious Diseases, now available online.

18 Oct 2005

Evidence is mounting to link toxoplasmosis with schizophrenia

Keep pet cats inside, stop feeding strays, cook meat sufficiently and reconsider the way the veterinary profession and public health agencies think - and teach - about the zoonotic pathogen Toxoplasma gondii.

18 Oct 2005

Bayer to produce new Tuberculosis drug at low prices for poor nations

A promising new antibiotic, moxifloxacin, produced by Bayer Healthcare is about to be tested against tuberculosis, a disease that kills 5,000 people a day.

18 Oct 2005

Antibiotic moxifloxacin as a new treatment for tuberculosis

Moxifloxacin is currently approved in more than 100 countries, including the United States, as a treatment for bacterial respiratory infections, such as bronchitis, sinusitis and pneumonia.

17 Oct 2005

$4.4 million, 4-year grant aims to bridge gap between Western and African medicine

Described as a hotspot of botanical diversity, there are more than 20,000 indigenous plant species in South Africa. Several thousand of them are used by traditional healers every day in that country for treating a range of problems from the common cold to serious diseases such as AIDS.

17 Oct 2005

Approval sought in the U.S. for 20 minute home HIV test

Authorities in the U.S. are considering the approval of the first rapid home testing kit for HIV.

17 Oct 2005

Fungal contamination of bedding

Researchers at The University of Manchester funded by the Fungal Research Trust have discovered millions of fungal spores right under our noses - in our pillows.

From The University of Manchester 16 Oct 2005

No shred of evidence that HIV-positive men who lose fat in their legs reciprocally gain fat in their bellies

There is no syndrome that causes increased belly fat and decreased facial and limb fat among HIV-positive men who take antiretroviral drugs, according to a study by researchers at the San Francisco VA Medical Center and the University of California, San Francisco.

13 Oct 2005

Tropical diseases such as sleeping sickness, schistosomiasis, river blindness, hookworm, elephantiasis, and blinding trachoma are being ignored

"The big three" infections AIDS, TB and malaria have caught the world's attention but other disabling and fatal infectious diseases in Africa are being ignored, say three eminent tropical disease researchers in the international health journal PLoS Medicine.

11 Oct 2005

Experimental HIV vaccine progresses in trials

A novel vaccine targeted to multiple HIV subtypes found worldwide has moved into the second phase of clinical testing, the National Institute of Allergy and Infectious Diseases (NIAID) announced today.

11 Oct 2005

New way to measure the impact of AIDS on the living brain

A new University of California - Los Angeles/University of Pittsburgh imaging study for the first time shows the selective pattern of destruction inflicted by AIDS on brain regions that control motor, language and sensory functions. High-resolution 3-D color scans created from magnetic resonance images (MRI) vividly illustrate the damage.

10 Oct 2005

Community-level intervention program successfully delayed sexual debut and increased the use of condoms

A community-level intervention program aimed at young adolescents delays early intercourse, increases condom use and reduces the type of risky sexual behavior that can result in sexually transmitted diseases and HIV/AIDS, a Yale researcher reports in AIDS.

4 Oct 2005

Compounds secreted by frog skin are potent blockers of HIV infection

The findings could lead to topical treatments for preventing HIV transmission, and they reinforce the value of preserving the Earth's biodiversity.

3 Oct 2005

Training for health workers improves the quality of tuberculosis care and control without requiring extra staff

Tuberculosis is a growing problem in lower and middle income countries, including South Africa. The World Health Organization estimates that about two thirds of people with tuberculosis are never diagnosed and so cannot benefit from treatment, leaving the epidemic unchecked despite global treatment programmes.

3 Oct 2005

Clinical trials of daily oral antiretroviral dosing as pre-exposure prophylaxis

Writing in the journal Science, an international team of researchers, clinicians and others explains that a promising, relatively new approach is for people not infected but at high risk to take drugs that might prevent them from contracting HIV. But debate over the particulars of the strategy has slowed progress.

3 Oct 2005

AIDS News and Research

Importance of the drug Fuzeon (enfuvirtide) in the management of HIV

US Congress has wasted an opportunity to tackle the rising numbers of chronically hungry people in the world

Zambia to try 'herbal remedy' as a treatment for HIV/AIDS

Survival rate of HIV-infected patients in India has risen in response to a 20-fold drop in the price of antiretroviral therapy

Third nationwide polio drive in Indonesia in attempt to eliminate the disease

HIV drug combo Trimethoprim-sulfamethoxazole highly effective at preventing malaria

Evidence is mounting to link toxoplasmosis with schizophrenia

Bayer to produce new Tuberculosis drug at low prices for poor nations

Antibiotic moxifloxacin as a new treatment for tuberculosis

$4.4 million, 4-year grant aims to bridge gap between Western and African medicine

Approval sought in the U.S. for 20 minute home HIV test

Fungal contamination of bedding

No shred of evidence that HIV-positive men who lose fat in their legs reciprocally gain fat in their bellies

Tropical diseases such as sleeping sickness, schistosomiasis, river blindness, hookworm, elephantiasis, and blinding trachoma are being ignored

Experimental HIV vaccine progresses in trials

New way to measure the impact of AIDS on the living brain

Community-level intervention program successfully delayed sexual debut and increased the use of condoms

Compounds secreted by frog skin are potent blockers of HIV infection

Training for health workers improves the quality of tuberculosis care and control without requiring extra staff

Clinical trials of daily oral antiretroviral dosing as pre-exposure prophylaxis

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News